Pediatrix Medical Group (NYSE:MD) Shares Gap Up – Time to Buy?

Pediatrix Medical Group, Inc. (NYSE:MD)’s share price gapped up prior to trading on Monday . The stock had previously closed at $12.44, but opened at $13.18. Pediatrix Medical Group shares last traded at $12.98, with a volume of 35,468 shares traded.

Analysts Set New Price Targets

MD has been the subject of a number of recent research reports. UBS Group lifted their price target on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the company a “neutral” rating in a research report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft boosted their price target on Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Mizuho raised their price objective on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Tuesday, November 19th. Jefferies Financial Group boosted their target price on Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Finally, Macquarie initiated coverage on Pediatrix Medical Group in a report on Monday, December 16th. They set an “outperform” rating and a $18.00 price target for the company. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $16.25.

Pediatrix Medical Group Trading Up 2.4 %

The stock has a fifty day simple moving average of $14.22 and a 200 day simple moving average of $11.71. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.42 and a current ratio of 1.42. The firm has a market cap of $1.17 billion, a P/E ratio of -4.45, a price-to-earnings-growth ratio of 2.00 and a beta of 1.58.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Friday, November 1st. The company reported $0.44 EPS for the quarter, topping the consensus estimate of $0.37 by $0.07. The company had revenue of $511.20 million during the quarter, compared to the consensus estimate of $498.87 million. Pediatrix Medical Group had a positive return on equity of 12.79% and a negative net margin of 12.65%. Pediatrix Medical Group’s revenue for the quarter was up .9% on a year-over-year basis. During the same period last year, the company earned $0.29 EPS. On average, research analysts expect that Pediatrix Medical Group, Inc. will post 1.26 earnings per share for the current fiscal year.

Insider Activity at Pediatrix Medical Group

In other news, EVP Mary Ann E. Moore sold 8,108 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $16.00, for a total transaction of $129,728.00. Following the completion of the sale, the executive vice president now owns 135,810 shares of the company’s stock, valued at $2,172,960. This represents a 5.63 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Mark S. Ordan sold 27,600 shares of the stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $15.35, for a total transaction of $423,660.00. Following the completion of the transaction, the director now owns 138,683 shares in the company, valued at $2,128,784.05. This trade represents a 16.60 % decrease in their position. The disclosure for this sale can be found here. 2.00% of the stock is owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Texas Permanent School Fund Corp grew its position in shares of Pediatrix Medical Group by 29.6% during the 2nd quarter. Texas Permanent School Fund Corp now owns 93,367 shares of the company’s stock valued at $705,000 after acquiring an additional 21,351 shares during the period. American Century Companies Inc. grew its holdings in Pediatrix Medical Group by 13.7% during the second quarter. American Century Companies Inc. now owns 124,395 shares of the company’s stock valued at $939,000 after purchasing an additional 15,023 shares during the period. WINTON GROUP Ltd increased its position in Pediatrix Medical Group by 33.9% in the second quarter. WINTON GROUP Ltd now owns 130,491 shares of the company’s stock worth $985,000 after buying an additional 33,057 shares in the last quarter. Vanguard Personalized Indexing Management LLC bought a new position in shares of Pediatrix Medical Group in the second quarter worth about $81,000. Finally, Hsbc Holdings PLC raised its stake in shares of Pediatrix Medical Group by 29.3% in the second quarter. Hsbc Holdings PLC now owns 30,502 shares of the company’s stock worth $227,000 after buying an additional 6,921 shares during the period. 97.71% of the stock is currently owned by institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.